I almost cried today listening to @LowderDallin thesis defense—what an incredible moment! He made the team immensely proud. Congratulations, Dr. Dallin Lowder! 🙌🎉🥳 This has been an extraordinary journey, and Dallin’s achievements speak for themselves—@PhRMAfoundation Predoctoral Fellow, @AACR & @PCF_Science Scholar-in-Training Awardee, @UrologySBUR Travel Award recipient, BCM Graduate School Dean’s Award for Excellence, and more! What a remarkable PhD journey! #ProudPI @bcmhouston@BCMDeptMedicine@BCMFromtheLabs
"Hit and run" one shot epigenetic silencing of the PCSK9 cholesterol gene with marked and prolonged LDL lowering
https://t.co/5gU6zw1SXt
—using mRNA-nanoparticle package
—potential alternative to DNA base editing
@Nature @justsaysinmice
PhRMA Foundation predoctoral awardees @LowderDallin & @RizwanKinza of @bcmhouston presented their research at the recent @AACR#AACR23 meeting. We love to see Foundation awardees sharing their work and networking at scientific conferences!
My wonderful team will be at the @AACR in full force! Come visit our posters and talks! Support us! Join us for 2023 AACR Runners for Research 5K Run/WalkI'm supporting American Association for Cancer Research! https://t.co/Azos5VilrP via @DonorDrive@KarenBerman78@LowderDallin@RizwanKinza@AmitK_Dash #AleksandraRusin #SaiManikonda
#Prostate cancer is the most common cancer in men. @LowderDallin is researching whether prostate cancer could be treated by blocking a specific type of proteins that drive dysregulated lipid metabolism, which plays a role in cancer progression. #PhRMAFdn22 https://t.co/vG4WL8Cfdm